Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2013 Nov 1.

Published in final edited form as: J Invest Dermatol. 2012 Nov 29;133(5):1188–1196. doi: 10.1038/jid.2012.403

Figure 2a, b, c — a). Cumulative incidence of recurrence among 667 patients with857 NMSCs at the university site. No statistically significant difference (P=0.09) detected in tumors treated with destruction, excision, or Mohs surgery.

b). Cumulative incidence of recurrence among 507 patients with 631 NMSCs at the VA site. No statistically significant difference (P=0.56) detected in tumors treated with destruction, excision, or Mohs surgery.

c). Cumulative incidence of recurrence among 1174 patients with 1488 NMSCs in the entire sample. No statistically significant difference (P=0.26) detected in tumors treated with destruction, excision, or Mohs surgery.

Figure 2a, b, c — a). Cumulative incidence of recurrence among 667 patients with857 NMSCs at the university site. No statistically significant difference (P=0.09) detected in tumors treated with destruction, excision, or Mohs surgery.

b). Cumulative incidence of recurrence among 507 patients with 631 NMSCs at the VA site. No statistically significant difference (P=0.56) detected in tumors treated with destruction, excision, or Mohs surgery.

c). Cumulative incidence of recurrence among 1174 patients with 1488 NMSCs in the entire sample. No statistically significant difference (P=0.26) detected in tumors treated with destruction, excision, or Mohs surgery.